Delivery and ridesharing services provider Grab Holdings ( GRAB -3.15%) didn't provide its investors with much of a lift in ...

We've already established that Verizon pays a higher dividend yield, trades at a lower valuation, and operates at higher ...

The three best-performing stocks on the S&P 500 this year have been Sandisk ( SNDK -2.73%), Moderna ( MRNA -7.20%), and Dell ...

Because it is a monopoly, AMSL typically carries a very high multiple. For 2030, analysts project EPS of $101.57, and if we ...

Regardless of Anthropic's IPO timing, the more important question for investors is whether its explosive growth can justify ...

SpaceX trades at a lofty valuation, even if you account for its projected $100 billion in annual recurring revenue. These ...

Shares of Option Care Health ( OPCH +32.93%) rocketed higher on Tuesday, climbing as much as 33.1%. As of 1:46 p.m. ET, the stock was still up 33%. The catalyst that sent the specialty healthcare ...

Vistra just landed a conditional $4.2 billion DOE loan. The deal reveals something much bigger for investors in nuclear ...

JPMorgan's Overweight call and $19 price target, combined with Corteva's move into the S&P MidCap 400, fueled a 12% surge, ...

Many investors initially thought the Paramount-Warner Bros. Discovery merger would struggle to get over the finish line due ...

Mega-cap stocks are those with a market cap of $200 billion or more. Despite all the focus on these stocks, they account for ...

On Sept. 10, HSBC analyst Rajesh Kumar maintained his "buy" rating on AbbVie ( ABBV +0.53%), raising his price target on the ...